LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 277

Search options

  1. Article ; Online: Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding - the promise, controversies and future directions.

    Wong, Yu Jun / Abraldes, Juan G

    Alimentary pharmacology & therapeutics

    2024  Volume 59, Issue 7, Page(s) 889–890

    MeSH term(s) Humans ; Terlipressin/therapeutic use ; Esophageal and Gastric Varices/drug therapy ; Gastrointestinal Hemorrhage/drug therapy ; Lypressin/therapeutic use ; Administration, Intravenous
    Chemical Substances Terlipressin (7Z5X49W53P) ; Lypressin (50-57-7)
    Language English
    Publishing date 2024-03-10
    Publishing country England
    Document type Editorial
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17882
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Noninvasive assessment oesophageal varices: impact of the Baveno VI criteria.

    Bai, Wayne / Abraldes, Juan G

    Current opinion in gastroenterology

    2022  Volume 38, Issue 3, Page(s) 206–215

    Abstract: Purpose of review: In 2015, as a consequence of the high development in noninvasive tests, Baveno VI consensus recommended for the first time the use of a prediction rule (liver stiffness ... 150000) to identify patients at low ... ...

    Abstract Purpose of review: In 2015, as a consequence of the high development in noninvasive tests, Baveno VI consensus recommended for the first time the use of a prediction rule (liver stiffness <20kPa and platelet count > 150000) to identify patients at low risk of having varices and that could circumvent endoscopy. These became known as the Baveno VI criteria. We review here the data validating Baveno VI criteria and we discuss the attempts of expanding these criteria.
    Recent findings: We report 28 studies assessing the performance of Baveno VI criteria showing a pooled 99% negative predictive value for ruling out high-risk varices. Performance is not affected by the cause of cirrhosis. Different attempts at expanding these criteria show suboptimal performance. Nonelastography-based criteria require further validation.
    Summary: Baveno VI criteria can be safely used to avoid endoscopy in a substantial proportion of patients with compensated cirrhosis. The progressive change in approach to the management of compensated cirrhosis, progressively focusing on treating portal hypertension with beta-blockers independently of the presence of varices, might render these criteria less relevant.
    MeSH term(s) Elasticity Imaging Techniques ; Endoscopy, Gastrointestinal ; Esophageal and Gastric Varices/diagnosis ; Esophageal and Gastric Varices/etiology ; Esophageal and Gastric Varices/therapy ; Humans ; Liver Cirrhosis/complications ; Varicose Veins
    Language English
    Publishing date 2022-03-02
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 632571-3
    ISSN 1531-7056 ; 0267-1379
    ISSN (online) 1531-7056
    ISSN 0267-1379
    DOI 10.1097/MOG.0000000000000824
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Carvedilol in patients with cirrhosis and arterial hypertension: two birds with one stone.

    Moctezuma-Velazquez, Carlos / Abraldes, Juan G

    Journal of hypertension

    2023  Volume 41, Issue 11, Page(s) 1864–1865

    MeSH term(s) Humans ; Carvedilol/therapeutic use ; Hypertension/complications ; Hypertension/drug therapy ; Liver Cirrhosis/complications ; Propanolamines/therapeutic use ; Adrenergic beta-Antagonists/therapeutic use
    Chemical Substances Carvedilol (0K47UL67F2) ; Propanolamines ; Adrenergic beta-Antagonists
    Language English
    Publishing date 2023-10-05
    Publishing country Netherlands
    Document type Letter
    ZDB-ID 605532-1
    ISSN 1473-5598 ; 0263-6352 ; 0952-1178
    ISSN (online) 1473-5598
    ISSN 0263-6352 ; 0952-1178
    DOI 10.1097/HJH.0000000000003528
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Editorial: The use of Baveno VI and VII criteria in patients with hepatocellular carcinoma.

    Moctezuma-Velazquez, Carlos / Abraldes, Juan G

    Alimentary pharmacology & therapeutics

    2023  Volume 58, Issue 4, Page(s) 478–479

    MeSH term(s) Humans ; Carcinoma, Hepatocellular/diagnosis ; Carcinoma, Hepatocellular/drug therapy ; Esophageal and Gastric Varices ; Liver Neoplasms/diagnosis ; Liver Neoplasms/drug therapy ; Liver Cirrhosis ; Elasticity Imaging Techniques
    Language English
    Publishing date 2023-07-25
    Publishing country England
    Document type Editorial ; Comment
    ZDB-ID 639012-2
    ISSN 1365-2036 ; 0269-2813 ; 0953-0673
    ISSN (online) 1365-2036
    ISSN 0269-2813 ; 0953-0673
    DOI 10.1111/apt.17626
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Statins for Chronic Liver Disease and the Need for Randomized Controlled Trials.

    Abraldes, Juan G / Moctezuma-Velazquez, Carlos

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2023  Volume 22, Issue 4, Page(s) 708–709

    MeSH term(s) Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Randomized Controlled Trials as Topic ; Liver Diseases/drug therapy
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2023-07-15
    Publishing country United States
    Document type Editorial
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2023.07.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Nonalcoholic Fatty Liver Disease: A Special Consideration in Transjugular Intrahepatic Portosystemic Shunts?

    Wang, Sarah / Abraldes, Juan G

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

    2021  Volume 27, Issue 3, Page(s) 323–324

    MeSH term(s) Diabetes Mellitus ; Humans ; Kidney Diseases ; Liver Transplantation/adverse effects ; Non-alcoholic Fatty Liver Disease/epidemiology ; Non-alcoholic Fatty Liver Disease/surgery ; Portasystemic Shunt, Transjugular Intrahepatic/adverse effects
    Language English
    Publishing date 2021-02-15
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 2006866-9
    ISSN 1527-6473 ; 1527-6465
    ISSN (online) 1527-6473
    ISSN 1527-6465
    DOI 10.1002/lt.25976
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: A model including standardized weight improved predicting waiting list mortality in adolescent liver transplant candidates: A US national study.

    Shaheen, Abdel Aziz / Martin, Steven R / Khorsheed, Sahar / Abraldes, Juan G

    Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society

    2023  Volume 30, Issue 3, Page(s) 269–276

    Abstract: The Model for End-Stage Liver Disease (MELD) score has been employed to identify adolescents eligible for liver transplantation since 2004. However, the optimal model for prioritizing adolescent candidates is uncertain. In our study, we aimed at ... ...

    Abstract The Model for End-Stage Liver Disease (MELD) score has been employed to identify adolescents eligible for liver transplantation since 2004. However, the optimal model for prioritizing adolescent candidates is uncertain. In our study, we aimed at evaluating the value of adding anthropometric variables to liver transplantation allocation models among adolescents. We conducted a retrospective cohort study using the data from the Organ Procurement and Transplantation Network Standard Transplant Analysis and Research to identify adolescent patients registered on the liver transplant waiting list in the United States between January 1, 2003, and December 31, 2022. Adolescents (12-17 y) who were listed for their first liver transplantation were included. We evaluated the performance of different models including pediatric end-stage liver disease with Na and creatinine, MELD, and MELD 3.0. Furthermore, we evaluated whether adding anthropometric variables ( z -score for weight and height) would improve the models' performance for our primary outcome (mortality at 90 days after listing). We identified 1421 eligible adolescent patients. Adding a z -score of weight (MELD-TEEN) improved the performance and discrimination of the MELD score. The final model including weight z -score (MELD-TEEN) had better discriminative power compared to MELD 3.0 and pediatric end-stage liver disease with Na and creatinine in the overall cohort and in different age groups (ages 12-14 and 15-17). MELD-TEEN could improve the accuracy of allocation of liver transplants among adolescents by incorporating the weight z -score compared to MELD 3.0 and pediatric end-stage liver disease with Na and creatinine.
    MeSH term(s) Humans ; Adolescent ; Child ; United States/epidemiology ; Liver Transplantation/adverse effects ; End Stage Liver Disease/diagnosis ; End Stage Liver Disease/surgery ; Retrospective Studies ; Waiting Lists ; Creatinine ; Severity of Illness Index ; Tissue and Organ Procurement
    Chemical Substances Creatinine (AYI8EX34EU)
    Language English
    Publishing date 2023-09-04
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 2006866-9
    ISSN 1527-6473 ; 1527-6465
    ISSN (online) 1527-6473
    ISSN 1527-6465
    DOI 10.1097/LVT.0000000000000251
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Update in the Treatment of the Complications of Cirrhosis.

    Abraldes, Juan G / Caraceni, Paolo / Ghabril, Marwan / Garcia-Tsao, Guadalupe

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

    2023  Volume 21, Issue 8, Page(s) 2100–2109

    Abstract: Cirrhosis consists of 2 main stages: compensated and decompensated, the latter defined by the development/presence of ascites, variceal hemorrhage, and hepatic encephalopathy. The survival rate is entirely different, depending on the stage. Treatment ... ...

    Abstract Cirrhosis consists of 2 main stages: compensated and decompensated, the latter defined by the development/presence of ascites, variceal hemorrhage, and hepatic encephalopathy. The survival rate is entirely different, depending on the stage. Treatment with nonselective β-blockers prevents decompensation in patients with clinically significant portal hypertension, changing the previous paradigm based on the presence of varices. In patients with acute variceal hemorrhage at high risk of failure with standard treatment (defined as those with a Child-Pugh score of 10-13 or those with a Child-Pugh score of 8-9 with active bleeding at endoscopy), a pre-emptive transjugular intrahepatic portosystemic shunt (TIPS) improves the mortality rate and has become the standard of care in many centers. In patients with bleeding from gastrofundal varices, retrograde transvenous obliteration (in those with a gastrorenal shunt) and/or variceal cyanoacrylate injection have emerged as alternatives to TIPS. In patients with ascites, emerging evidence suggests that TIPS might be used earlier, before strict criteria for refractory ascites are met. Long-term albumin use is under assessment for improving the prognosis of patients with uncomplicated ascites and confirmatory studies are ongoing. Hepatorenal syndrome is the least common cause of acute kidney injury in cirrhosis, and first-line treatment is the combination of terlipressin and albumin. Hepatic encephalopathy has a profound impact on the quality of life of patients with cirrhosis. Lactulose and rifaximin are first- and second-line treatments for hepatic encephalopathy, respectively. Newer therapies such as L-ornithine L-aspartate and albumin require further assessment.
    MeSH term(s) Humans ; Esophageal and Gastric Varices/complications ; Hepatic Encephalopathy/etiology ; Hepatic Encephalopathy/therapy ; Ascites/etiology ; Ascites/therapy ; Quality of Life ; Portasystemic Shunt, Transjugular Intrahepatic/adverse effects ; Gastrointestinal Hemorrhage/etiology ; Gastrointestinal Hemorrhage/therapy ; Treatment Outcome ; Liver Cirrhosis/complications ; Liver Cirrhosis/therapy ; Varicose Veins/complications
    Language English
    Publishing date 2023-03-25
    Publishing country United States
    Document type Journal Article ; Review ; Research Support, N.I.H., Extramural
    ZDB-ID 2119789-1
    ISSN 1542-7714 ; 1542-3565
    ISSN (online) 1542-7714
    ISSN 1542-3565
    DOI 10.1016/j.cgh.2023.03.019
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Pre-emptive TIPSS in Acute Variceal Bleeding: Current Status, Controversies, and Future Directions.

    Wong, Yu Jun / Ho, Wei Ling Danielle / Abraldes, Juan G

    Journal of clinical and translational hepatology

    2022  Volume 10, Issue 6, Page(s) 1223–1228

    Abstract: Acute variceal bleeding (AVB) is associated with significant short-term morbidity and mortality. Pre-emptive transjugular intrahepatic portosystemic shunt (p-TIPSS) is recommended to prevent rebleeding in AVB patients with a high risk of rebleeding. ... ...

    Abstract Acute variceal bleeding (AVB) is associated with significant short-term morbidity and mortality. Pre-emptive transjugular intrahepatic portosystemic shunt (p-TIPSS) is recommended to prevent rebleeding in AVB patients with a high risk of rebleeding. Despite the benefit of preventing rebleeding and
    Language English
    Publishing date 2022-07-29
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 3019822-7
    ISSN 2310-8819 ; 2225-0719
    ISSN (online) 2310-8819
    ISSN 2225-0719
    DOI 10.14218/JCTH.2022.00240
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article: How strong is the evidence to support statins repurposing for the treatment of cirrhosis?

    Moctezuma-Velázquez, Carlos / Abraldes, Juan G

    Revista espanola de enfermedades digestivas

    2022  Volume 115, Issue 3, Page(s) 107–109

    Abstract: In this editorial, we briefly mention the studies that support the use of statins to change the natural history of liver cirrhosis, alongside potential biases and flaws that need to be considered when analyzing data. The key message that we want to ... ...

    Abstract In this editorial, we briefly mention the studies that support the use of statins to change the natural history of liver cirrhosis, alongside potential biases and flaws that need to be considered when analyzing data. The key message that we want to communicate is that even if current evidence is somehow compelling, it is limited, mostly from observational studies, and in general not enough to formally recommend the prescription of statins in patients with cirrhosis as disease-modifying agents. Finally, we also mention some important facts about the safety of statins in the context of patients with underlying liver disease.
    MeSH term(s) Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Liver Cirrhosis/complications ; Liver Cirrhosis/drug therapy ; Liver Diseases
    Chemical Substances Hydroxymethylglutaryl-CoA Reductase Inhibitors
    Language English
    Publishing date 2022-11-10
    Publishing country Spain
    Document type Journal Article
    ZDB-ID 1070381-0
    ISSN 1130-0108 ; 0212-7512
    ISSN 1130-0108 ; 0212-7512
    DOI 10.17235/reed.2022.9281/2022
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top